Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-10-24
1998-03-03
Knode, Marian C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 13, 514 14, 530300, 530350, 530371, A61K 3804, A61K 3816, C07K 14395
Patent
active
057234361
ABSTRACT:
An identification and characterization of a calcineurin interacting protein effective to enhance immunosuppressive effects of calcineurin-targeted immunosuppressants by potentiating an interaction of an immunophilin with calcineurin is described herein. One embodiment of the invention is the CNI polypeptide encoded by the CNI gene of Saccharomyces cerevisiae. Polynucleotides encoding a CNI protein are also described. Also described are yeast cells carrying mutations in the CNI gene. Further, a method of identifying a small molecule immunosuppressant compound is described. The methods include the use of a cell-based two hybrid protein-protein interaction assay, wherein one of two fusion hybrid proteins in a cell contains a subunit of calcineurin, and the other of two fusion hybrid proteins contains an immunophilin.
REFERENCES:
Reeck et al., Cell, vol. 50, p. 667, 1987.
Chien, C.-T., et al., "The Two-Hybrid System: a Method to Identify and Clone Genes for Proteins that Interact with a Protein of Interest," Proc. Natl. Acad. Sci. U.S.A. 88:9578-9582 (1991).
Clipstone, N.A., and Crabtree, G.R., "Identification of Calcineurin as a Key Signalling Enzyme in T-Lymphocyte Activation," Nature 357:695-697 (1992).
Cyert, M.S., "Immunosuppressants Hit the Target," Current Biology 2(1):18 (1992).
Dujon, B., et al., "Complete DNA Sequence of Yeast Chromosome XI," Nature 369:371-378 (1994).
Durfee, T., et al., "The Retinoblastoma Protein Associates with the Protein Phosphatase Type 1 Catalytic Subunit," Genes & Development 7:555-569 (1993).
Fields, S., and Song, O.-k., "A Novel Genetic System to Detect Protein-Protein Interactions," Nature 340:245-246 (1989).
Foor, F., et al., "Calcineurin Mediates Inhibition by FK506 and Cyclosporin of Recovery from .alpha.-Factor Arrest in Yeast," Nature 360:682-684 (1992).
Pflugl, G., et al., "X-Ray Structure of a Decameric Cyclophilin-Cyclosporin Crystal Complex," Nature 361:91-94 (1993).
Rogers, S., et al., "Amino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis," Science 234;364-368 (1986).
Steiner, J.P., et al., "High Brain Densities of the Immunophilin FKBP Colocalized with Calcineurin," Nature 358:584-587 (1992).
Yang, X., et al., "A Protein Kinase Substrate Identified by the Two-Hybrid System," Science 257:680-682 (1992).
Cyert Martha S.
Huang Laiqiang
Gucker Stephen
Knode Marian C.
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Calcineurin interacting protein compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcineurin interacting protein compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcineurin interacting protein compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2247693